We are live on ! Find out more
IIP

Intermede Investment Partners Portfolio holdings

AUM $2.16B
1-Year Est. Return 18.47%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+18.47%
3 Year Est. Return
+69.55%
5 Year Est. Return
+72.34%
10 Year Est. Return
+364.13%
AUM
$1.03B
AUM Growth
+$77M
Cap. Flow
+$30M
Cap. Flow %
2.9%
Top 10 Hldgs %
54.04%
Holding
26
New
1
Increased
14
Reduced
9
Closed
2

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$44.5M
2
CME icon
CME Group
CME
+$8.9M
3
WFC icon
Wells Fargo
WFC
+$8.38M
4
AGN
Allergan plc
AGN
+$7.7M
5
TJX icon
TJX Companies
TJX
+$6.94M

Sector Composition

Rank Sector Weight
1 Healthcare 21.61%
2 Financials 20.08%
3 Communication Services 17.43%
4 Technology 13.68%
5 Consumer Discretionary 10.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BABA icon
1
Alibaba
BABA
$269B
$69M 6.68%
490,029
-13,643
-3% -$1.68M
AGN
2
DELISTED
Allergan plc
AGN
$62.2M 6.02%
255,915
+32,754
+15% +$7.7M
MA icon
3
Mastercard
MA
$477B
$58.6M 5.67%
482,453
+166
+0% +$19.7K
CMCSA icon
4
Comcast
CMCSA
$79.1B
$56.4M 5.45%
1,448,606
+407
+0% +$16K
GOOG icon
5
Alphabet (Google) Class C
GOOG
$3.9T
$55.5M 5.37%
1,221,480
-69,380
-5% -$3.18M
MDT icon
6
Medtronic
MDT
$107B
$55.1M 5.33%
620,505
+1,931
+0.3% +$163K
ALLE icon
7
Allegion
ALLE
$13B
$51.8M 5.01%
638,735
+6
+0% +$470
CME icon
8
CME Group
CME
$92.2B
$51.1M 4.95%
408,368
+74,393
+22% +$8.9M
TSM icon
9
TSMC
TSM
$2.09T
$50.1M 4.84%
1,432,758
-1,598
-0.1% -$55.3K
ORCL icon
10
Oracle
ORCL
$331B
$49M 4.74%
+977,018
New +$44.5M
ANSS
11
DELISTED
Ansys
ANSS
$42.4M 4.1%
348,719
-21,756
-6% -$2.56M
SCHW
12
Charles Schwab
SCHW
$177B
$41.1M 3.97%
955,720
+104,226
+12% +$4.17M
AMGN icon
13
Amgen
AMGN
$203B
$40.2M 3.88%
233,156
+340
+0.1% +$55.3K
COL
14
DELISTED
Rockwell Collins
COL
$38.5M 3.72%
365,989
-70
-0% -$7.25K
META icon
15
Meta Platforms (Facebook)
META
$1.51T
$37M 3.58%
245,331
+48
+0% +$7.14K
DHR icon
16
Danaher
DHR
$135B
$36.9M 3.57%
493,426
+143
+0% +$10.7K
TJX icon
17
TJX Companies
TJX
$170B
$36.4M 3.52%
1,008,338
+184,052
+22% +$6.94M
WFC icon
18
Wells Fargo
WFC
$261B
$33.1M 3.2%
597,516
+156,412
+35% +$8.38M
ECL icon
19
Ecolab
ECL
$75.6B
$32.2M 3.11%
242,194
+26,314
+12% +$3.4M
LBTYA icon
20
Liberty Global Class A
LBTYA
$3.31B
$31.3M 3.03%
974,857
-265
-0% -$8.49K
BIIB icon
21
Biogen
BIIB
$29.9B
$29.1M 2.81%
107,220
+83
+0.1% +$21.9K
DLTR icon
22
Dollar Tree
DLTR
$23.1B
$28.5M 2.76%
408,175
-38
-0% -$2.93K
HDS
23
DELISTED
HD Supply Holdings, Inc.
HDS
$24.8M 2.4%
810,952
-9
-0% -$340
SPGI icon
24
S&P Global
SPGI
$126B
$23.8M 2.3%
162,704
-45
-0% -$6.25K
CHKP icon
25
Check Point Software Technologies
CHKP
$13.3B
-226,472
Closed -$23.3M

Similar funds

Intermede Investment Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Intermede Investment Partners held 26 positions worth $1.03B, up 8% from $957M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Intermede Investment Partners's Q2 2017 filing shows 1 new, 14 increased, 9 reduced and 2 closed positions. Its largest new stake was Oracle: 977,018 shares worth $49M. The largest sale was Fidelity National Information Services, an estimated $23.6M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Communication Services.

  • Intermede Investment Partners's largest Q2 2017 buy was Oracle: 977,018 shares worth $49M.
  • Intermede Investment Partners added most to CME Group in Q2 2017, an estimated $8.9M increase.
  • Intermede Investment Partners's biggest Q2 2017 reduction was Alphabet (Google) Class C, cutting an estimated $3.18M.
  • Intermede Investment Partners fully exited Fidelity National Information Services in Q2 2017, selling an estimated $23.6M.
  • Intermede Investment Partners's ten largest holdings make up 54% of its $1.03B portfolio in Q2 2017.
  • Intermede Investment Partners opened 1 new position and closed 2 in Q2 2017.
  • Intermede Investment Partners's portfolio value rose 8% quarter-over-quarter to $1.03B.

Based on Intermede Investment Partners's 13F filing for Q2 2017, filed 17 Jul 2017.